Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies
This study has been terminated.
Study NCT00038207 Information provided by M.D. Anderson Cancer Center
First Received: May 29, 2002 Last Updated: November 14, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Soft Tissue Sarcoma
Lymphoma
Leukemia
Wilms' Tumor
Osteosarcoma
Additional conditions recognized in this trial
Sarcoma
Wilms Tumor
More general conditions related to this trial
Genetic Diseases, Inborn
Immune System Diseases
Immunoproliferative Disorders
Kidney Diseases
Kidney Neoplasms
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Bone Tissue
Neoplasms, Complex and Mixed
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplastic Syndromes, Hereditary
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
Liposomal Vincristine
Additional drug interventions recognized in this trial
Vincristine
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
M.D. Anderson Cancer Center
Back to top of Main Content
